Department of Health Services Logo


Wisconsin Department of Health Services

Mendota Home

About Mendota





Concerns Regarding Patient Care


Mendota Mental Health Institute - Citations and Publications by John Battaglia, M.D.

Doorack, J.L: Allen, J, Battaglia, J: Co-occurring SAD and schizophrenia in Alaska- a pilot study. Manuscript submitted.

Battaglia, J, Houston JP, Ahl, J, Meyers AL, Kaiser, CJ: A post hoc analysis of oral transition dose over 4 days following 24-hour intramuscular treatment with olanzapine or haloperidol in acutely agitated adult patients with schizophrenia. Clinical Therapeutics, 2005; 27: 1612 - 1618.

Warner, TD, Monaghan-Geernaert P, Battaglia J, Brems C, Johnson ME, Roberts, LW: Ethical considerations in rural health care: a pilot study of Clinicians in Alaska and New Mexico. Community Mental Health Journal, 2005, 41(1); 21 - 33.

Battaglia, J: Pharmacologic management of acutely agitated patients. Drugs; 2005, 65 (9): 1207- 1222.

Zimbroff DL, Allen MH, Battaglia, J, et al: Best clinical practice with intramuscular ziprasidone: Update after 2 years of experience. CNS Spectrums, 2005, 10 (9-Suppl 11): 1 - 15.

Battaglia, J: Agitation in the inpatient setting. Psychiatric Issues in Emergency Settings, 2005, 4 (1): 13 - 19.

Battaglia, J: Is this patient dangerous? 5 steps to assess risk for violence. Current Psychiatry, 2004, 3 (2): 14 - 21.

Battaglia, J: Intramuscular olanzapine: treating acute agitation in psychosis and bipolar mania. Current Psychiatry, 2004, 3 (5): 76 - 78.

Battaglia, J: Agitation in bipolar disorder and schizophrenia. Psychiatric Issues in Emergency Settings, 2004, 3 (3): 5 - 8.

Battaglia, J/Stacy, D: Alaka, K: Meehan, K: Wright, P: To Sleep or Not to Sleep? Calming versus sedative effects of intramuscular olanzapine in agitated patients. American Journal of Emergency Medicine, 2003; 21: 192 - 198.

Wright, P, Lindborg, SR, Birkett, M, Meehan, K, Jones, B, Alaka, K, Ferchland-Howe, I, Pickard, A, Taylor, CC, Roth, J, Battaglia, J, Bitter, I, Chouinard, G, Morris, P, Brier, A: Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: Antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment. Canadian Journal of Psychiatry, 2003; 48: 716-721.

Battaglia, J: Reflections on a day in the life of an academic psychiatrist. Academic Psychiatry, Fall 2003; 27 (3): 218 - 220.

Battaglia, J: David, SR: Alaka, K: Meehan, K: Wright, P: Calming versus Sedative Effects of IM Olanzapine in Agitated Patients. Winter Workshop on Schizophrenia, Davos, Switzerland, February 2002. Schizophrenia Research 2002; 53 (3): 182

David, SR: Battaglia, J: Alaka, K: Meehan, K: Wright, P: Calming versus Sedative Effects of IM Olanzapine in Agitated Patients.  Society of Biological Psychiatry, Philadelphia, PA, May 2002. Biological Psychiatry 2002: 51 (8S): 197S.

Battaglia, J: David, SR: Alaka, K: Meehan, K: Wright, P: Calming versus Sedative Effects of IM Olanzapine in Agitated Patients. European College of Neuropsychopharmacology, Barcelona, Spain, October 2002. European Neuropsychopharmacology, 2002.

Roberts, L. W: Battaglia, J. et al: Stigma, Ethics and the Frontier. Challenges in caring for people with serious illnesses in Alaska and New Mexico. Arctic Research of the United States, 2001; 15: 2 - 15.

Mendota Mental Health Institute
301 Troy Drive, Madison, WI 53704
Phone:(608) 301-1000 Fax:(608) 301-1358
TTY/TDD:(888) 241-9442

Last Revised: April 16, 2014